Everything about Healthcare News
Novo CEO pressed by Senate to cut costs of being overweight, diabetic issues medicine CEO Lars Fruergaard Jørgensen advised lawmakers the company would look at new talks with insurers with regard to the listing price ranges of Wegovy and copyright whenever they pledge to help keep the medicines on their own formularies.Never miss tomorrow's health